Brainstorm Cell Therapeutics  logo
Brainstorm Cell Therapeutics BCLI
$ 1.11 -5.34%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Brainstorm Cell Therapeutics Total Liabilities 2011-2024 | BCLI

Annual Total Liabilities Brainstorm Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
9.07 M 11.5 M 9.94 M 15.8 M 18.8 M 6.21 M 5.54 M 864 K 2.95 M 3.24 M 1.99 M 1.33 M 1.26 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.8 M 864 K 6.8 M

Quarterly Total Liabilities Brainstorm Cell Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
9.21 M 8.9 M 9.07 M 8.26 M 9.63 M 12.7 M 11.5 M 11.9 M 11.1 M 11.3 M 9.94 M 9.61 M 12.1 M 12.4 M 15.8 M 15.8 M 15.8 M 15.8 M 18.8 M 18.8 M 18.8 M 18.8 M 6.21 M 6.21 M 6.21 M 6.21 M 5.54 M 5.54 M 5.54 M 5.54 M 864 K - - - 2.95 M 2.84 M 2.53 M 2.73 M 3.24 M 3.24 M 3.24 M 3.24 M 1.99 M 1.99 M 1.99 M 1.99 M 1.16 M 1.33 M 1.33 M 1.33 M 1.26 M 1.26 M 1.26 M 1.26 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
18.8 M 864 K 7.37 M